“PO-14 | Pain catastrophizing in chronic migraine patients receiving eptinezumab treatment: Alessandra Parisi,1 Licia Grazzi,1 Alberto Raggi,2 Giulia Regonesi,1 Montisano Danilo Antonio1 | 1Headache Center, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano; 2Neurology, Public Health and Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy” (2025) Confinia Cephalalgica, 35(S1). doi:10.4081/cc.2025.15835.